Textual content signal exhibiting Trade Information. Enterprise photograph textual content delivering information to most people or a goal public | Picture Credit score: © Artur – inventory.adobe.com
Almac Pharma Companies, part of Almac Group, formally opened a brand new, state-of-the-art, £65 million (US$84.2 million) industrial manufacturing facility in Craigavon, United Kingdom, on March 11, 2025 (1). The Northern Eire web site can also be dwelling to Almac’s world headquarters.
Development of the power was accomplished in late 2024, and, in response to Almac, manufacture of fine manufacturing follow batches will start by March 18, 2025 pending profitable completion of validation actions on the regulatory accepted Middle of Excellence (1).
Measuring 100,000 sq. toes, the power enhances present capabilities, the corporate reported, in industrial oral dose therapy manufacturing in a wide range of therapeutic areas, with high-specification manufacturing suites, an extension to present manufacturing scales of potent and extremely potent drug merchandise, and alternatives for associate corporations to put in customized expertise or that which is devoted to be tailor-made to these corporations’ wants (1)
“We’re thrilled to formally open our new industrial manufacturing facility at our world headquarters web site,” John McQuaid, president and managing director of Almac Pharma Companies, mentioned in an organization press launch (1). “This funding underscores our dedication to supporting our shoppers’ rising wants with the best stage of service and experience … The brand new facility not solely expands our vary of capabilities but additionally reinforces our place as an trade chief in pharmaceutical improvement and industrial manufacturing with a capability to tailor our providers to swimsuit particular person merchandise. It additionally demonstrates our dedication to working in true partnership with our shoppers as we assist them in bringing vital new therapies to the sufferers we serve.”
At CPHI Milan in October 2024, Pharmaceutical Know-how Europe™ spoke with McQuaid in regards to the challenges in offering providers that face contract improvement and manufacturing organizations amid a rising pharmaceutical trade, greater demand for analytical providers, and tendencies for future funding (2).
In line with McQuaid, at the moment, Almac’s plans for enlargement have been properly on their strategy to taking form.
“We’re investing in chilly chain capabilities, each for the medical phases and the industrial phases, after which we’ve got peptide synthesis coming on-line early subsequent 12 months [in 2025] at our API plant in Craigavon, with small molecule enlargement kicking in later subsequent 12 months, after which additional program for larger-scale API manufacturing,” he mentioned within the CPHI Milan interview (2).
In January 2025, Almac introduced a £500,000 (US$611,500 approximate) funding in state-of-the-art instrumentation for its spectroscopy laboratories on the Craigavon headquarters, particularly a quadrupole-time-of-flight mass spectrometer (6545XT AdvanceBio Q-TOF, Agilent) and a diffractometer (Empyrean X-Ray Powder Diffractometer, Malvern Panalytical) (3).
That instrumentation funding got here along with a beforehand introduced £11 million (US$14.7 million) spend, made public in October 2024, meant to develop the corporate’s world analytical providers capabilities and create 100 jobs, all of which adopted an preliminary £250 million (US$324 million) dedication in capital funding, together with an meant workforce progress of 1800, made in 2022; that funding, in response to Almac, has since elevated to greater than £400 million (US$518.5 million) (1,4).
View John McQuaid’s full interview with Pharmaceutical Know-how® from CPHI Milan 2024 right here.
References
1. Almac Group. Almac Pharma Companies Opens Doorways on £65m New Business Manufacturing Facility. Press Launch. March 11, 2025.
2. Thomas, F. CPHI Milan 2024: Pharma Trade Development and Funding. PharmTech.com, Oct. 11, 2024.
3. Almac Sciences. Almac Invests £500,000 in State-of-the-Artwork Instrumentation Inside Spectroscopy Laboratories. Press Launch. Jan. 16, 2025.
4. Almac Group. Almac Group Publicizes £11m Funding to Broaden International Analytical Companies. Press Launch. Oct. 1, 2024.
